NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 71 filers reported holding NOVELION THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 831,440 | $7,674,000 | 13.79% |
| Stonepine Capital Management, LLC | 1,852,395 | $17,098,000 | 9.23% |
| Sarissa Capital Management LP | 1,025,000 | $9,460,000 | 3.16% |
| Opaleye Management Inc. | 750,000 | $6,922,000 | 2.89% |
| Broadfin Capital, LLC | 1,948,554 | $17,985,000 | 2.18% |
| ARMISTICE CAPITAL, LLC | 1,852,000 | $17,094,000 | 2.18% |
| JW Asset Management, LLC | 315,980 | $2,916,000 | 1.86% |
| Tiger Legatus Capital Management, LLC | 450,000 | $4,154,000 | 1.69% |
| KNOTT DAVID M | 109,184 | $1,008,000 | 0.42% |
| Ancora Advisors LLC | 507,981 | $4,688,000 | 0.30% |